单位:[1]Department of Neurology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China华中科技大学同济医学院附属同济医院神经内科神经科[2]Department of Radiology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China华中科技大学同济医学院附属同济医院放射科[3]Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China[4]School of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing 100876, China[5]University of the Chinese Academy of Sciences, Beijing 100049, China
Grey matter (GM) alterations may contribute to cognitive decline in individuals with white matter hyperintensities (WMH) but no consensus has yet emerged. Here, we investigated cortical thickness and grey matter volume in 23 WMH patients with mild cognitive impairment (WMH-MCI), 43 WMH patients without cognitive impairment, and 55 healthy controls. Both WMH groups showed GM atrophy in the bilateral thalamus, fronto-insular cortices, and several parietal-temporal regions, and the WMH-MCI group showed more extensive and severe GM atrophy. The GM atrophy in the thalamus and fronto-insular cortices was associated with cognitive decline in the WMH-MCI patients and may mediate the relationship between WMH and cognition in WMH patients. Furthermore, the main results were well replicated in an independent dataset from the Alzheimer's Disease Neuroimaging Initiative database and in other control analyses. These comprehensive results provide robust evidence of specific GM alterations underlying WMH and subsequent cognitive impairment.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801146, 81871438, 81771341]; Natural Science Foundation of Hubei ProvinceNatural Science Foundation of Hubei Province [2017CFB392]; Beijing Natural Science Funds for Distinguished Young Scholars [JQ200036]; Flagship Program of Tongji Hospital, China [2019CR106]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); AbbVie; Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; BiogenBiogen; Bristol-Myers Squibb CompanyBristol-Myers Squibb; CereSpir, Inc.; Cogstate; Eisai Inc.Eisai Co Ltd; Elan Pharmaceuticals, Inc.; Eli Lilly and CompanyEli Lilly; EuroImmun; F. Hoffmann-La Roche LtdHoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech; Fujirebio; GE HealthcareGE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.Johnson & Johnson USA; NeuroRx Research; Novartis Pharmaceuticals CorporationNovartis; Pfizer Inc.Pfizer; Piramal Imaging; ServierServier; Transition Therapeutics; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Neurotrack Technologies; Lumosity; LundbeckLundbeck Corporation; Merck Co., Inc.Merck & Company; Meso Scale Diagnostics, LLC.; Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company Ltd
第一作者单位:[1]Department of Neurology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
共同第一作者:
通讯作者:
通讯机构:[3]Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China[4]School of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing 100876, China[5]University of the Chinese Academy of Sciences, Beijing 100049, China
推荐引用方式(GB/T 7714):
Zhu Wenhao,Huang Hao,Yang Shiqi,et al.Cortical and Subcortical Grey Matter Abnormalities in White Matter Hyperintensities and Subsequent Cognitive Impairment[J].NEUROSCIENCE BULLETIN.2021,37(6):789-803.doi:10.1007/s12264-021-00657-0.
APA:
Zhu, Wenhao,Huang, Hao,Yang, Shiqi,Luo, Xiang,Zhu, Wenzhen...&Alzheimer’s Disease Neuroimaging Initiative.(2021).Cortical and Subcortical Grey Matter Abnormalities in White Matter Hyperintensities and Subsequent Cognitive Impairment.NEUROSCIENCE BULLETIN,37,(6)
MLA:
Zhu, Wenhao,et al."Cortical and Subcortical Grey Matter Abnormalities in White Matter Hyperintensities and Subsequent Cognitive Impairment".NEUROSCIENCE BULLETIN 37..6(2021):789-803